Somrudee Reabroi

สมฤดี เรียบร้อย

  • B.Sc. (Pharmaceutical Science) Ubonratchathani University, Thailand
  • Ph.D. (Physiology) Mahidol University, Thailand
Current Research
  • Anticancer drug discovery
  • Cancer biology
  • Intracellular signaling pathways
  • Tumor xenograft models




  • Mazumder A., Assawapanumat W., Dwivedi A., Reabroi S., Chairoungdua A. & Nasongkla N. (2019). Glucose targeted therapy against liver hepatocellular carcinoma: In vivostudy, J Drug Deliv Sci Tech, 49: 502-512.
  • Reabroi S., Saeeng R., Boonmuen N., Kasemsuk T., Saengsawang W., Suksen K., Zhu W., Piyachaturawat P. & Chairoungdua A. (2018). The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells. Sci Rep, 8: 1-14.
  • Reabroi S., Chairoungdua A., Saeeng R., Kasemsuk T., Saengsawang W., Zhu W. & Piyachaturawat P. (2018). A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer. Biomed Pharmacother, 101: 414-421.
  • Puntawee S., Theerasilp M., Reabroi S., Saeeng R., Piyachaturawat P., Chairoungdua A. & Nasongkla N. (2015). Solubility enhancement and in vitro evaluation of PEG-b-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy. Dev. Technol.4: 1-8.
  • Nateewattana J., Dutta S., Reabroi S., Saeeng R., Kasemsook S., Chairoungdua A., Weerachayaporn J., Wongkham S. & Piyachaturawat P. (2014). Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition. J. Pharmacol. 723: 148-155.